The Pennant Group (NASDAQ:PNTG) Trading Up 8.7% – Still a Buy?

Shares of The Pennant Group, Inc. (NASDAQ:PNTG) traded up 8.7% during trading on Friday . The stock traded as high as $25.87 and last traded at $25.8210. 108,125 shares were traded during mid-day trading, a decline of 59% from the average session volume of 262,978 shares. The stock had previously closed at $23.75.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on PNTG shares. Truist Financial cut their price target on shares of The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Weiss Ratings reissued a “hold (c+)” rating on shares of The Pennant Group in a research report on Wednesday. Jefferies Financial Group initiated coverage on shares of The Pennant Group in a research note on Friday, October 24th. They issued a “buy” rating and a $30.00 price objective for the company. Wells Fargo & Company lowered their price target on The Pennant Group from $31.00 to $29.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 14th. Finally, Stephens reissued an “overweight” rating and set a $40.00 price objective on shares of The Pennant Group in a research report on Thursday, October 9th. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, The Pennant Group currently has an average rating of “Moderate Buy” and an average target price of $32.80.

The Pennant Group Price Performance

The stock has a market cap of $891.06 million, a P/E ratio of 34.57, a price-to-earnings-growth ratio of 2.07 and a beta of 1.39. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.11. The company’s fifty day simple moving average is $24.74 and its 200-day simple moving average is $25.81.

The Pennant Group (NASDAQ:PNTG) last issued its earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.01. The Pennant Group had a net margin of 3.15% and a return on equity of 9.52%. The business had revenue of $229.04 million for the quarter, compared to analyst estimates of $221.96 million. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, sell-side analysts forecast that The Pennant Group, Inc. will post 0.75 EPS for the current year.

Institutional Trading of The Pennant Group

Several institutional investors have recently bought and sold shares of the stock. Van Berkom & Associates Inc. raised its stake in The Pennant Group by 10.1% during the third quarter. Van Berkom & Associates Inc. now owns 3,112,812 shares of the company’s stock worth $78,505,000 after acquiring an additional 284,856 shares in the last quarter. 8 Knots Management LLC increased its position in shares of The Pennant Group by 23.9% during the 1st quarter. 8 Knots Management LLC now owns 3,014,023 shares of the company’s stock worth $75,803,000 after purchasing an additional 581,313 shares in the last quarter. Ophir Asset Management Pty Ltd lifted its holdings in The Pennant Group by 403.9% during the 2nd quarter. Ophir Asset Management Pty Ltd now owns 1,048,759 shares of the company’s stock valued at $31,305,000 after purchasing an additional 840,642 shares during the last quarter. Paradigm Capital Management Inc. NY boosted its position in The Pennant Group by 1.7% in the first quarter. Paradigm Capital Management Inc. NY now owns 955,000 shares of the company’s stock valued at $24,018,000 after buying an additional 16,000 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in The Pennant Group by 4.6% during the second quarter. Geode Capital Management LLC now owns 832,481 shares of the company’s stock worth $24,853,000 after buying an additional 36,357 shares during the last quarter. Institutional investors and hedge funds own 85.88% of the company’s stock.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.